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The Hedgehog signaling pathway regulates embryo patterning and progenitor cell homeostasis in adult
tissues, including epidermal appendages. A role for the Hh pathway in mammary biology and breast
cancer has also been suggested. The aim of this study was to analyze Hh signaling in the mouse
mammary gland through the generation of transgenic mice that express Sonic Hedgehog (Shh) under
the control of the mammary-speciﬁc WAP promoter (WAP-Shh mice). To identify mammary cells
capable of activating the Hh pathway we bred WAP-Shh mice to Ptch1-lacZ knock-in mice, in which the
expression of a nuclear-targeted b-galactosidase reporter protein (b-gal) is driven by the endogenous
Patched 1 gene regulatory region. After two cycles of induction of transgenic Shh expression, we
detected areas of X-gal reactivity. Immunohistochemical analysis showed nuclear b-gal staining in
clusters of mammary cells in WAP-Shh/Ptch1-lacZ bitransgenic mice. These were epithelial cells
present in a basal location of displastic ducts and alveoli, adjacent to Shh-expressing luminal cells, and
overexpressed epithelial basal markers keratin 5, 14 and 17 and transcription factor p63. Absence of
smooth muscle actin expression and a cuboidal morphology differentiated Hh-responding cells from
ﬂat-shaped mature myoepithelial cells. Groups of cells expressing stem cell markers integrin b3 and
keratins 6 and 15 were also detected within Hh-responding areas. In addition, we found that
Hh-responding cells in the mammary glands of WAP-Shh/Ptch1-lacZ mice were ciliated and exhibited
a low proliferation rate. Our data show the paracrine nature of hedgehog signaling in the epithelial
compartment of the mouse mammary gland, where a subset of basal cells that express mammary
progenitor cell markers and exhibit primary cilia is expanded in response to secretory epithelium-
derived Shh.
& 2012 Elsevier Inc. All rights reserved.Introduction
The Hedgehog (Hh) signal transduction pathway is a
fundamental regulator of embryonic development and tissue
homeostasis. Hh ligands bind to Patched membrane receptors,
activating the pathway through release of Smoothened inhibition
and subsequent activation of Gli transcription factors, which in
turn stimulate expression of downstream target genes. In verte-
brates, there are three Hh secreted ligands: Sonic (Shh), Indianll rights reserved.
olecular, Centro de Biologı´a
adrid, 28049 Madrid, Spain.(Ihh) and Desert (Dhh) hedgehog, and three Gli proteins. Gli1
works exclusively as an activator, but Gli2 and Gli3 can function
as activators or proteolytically processed repressors (Pan et al.,
2006; Wang et al., 2000). However, a number of studies show that
Gli3 works predominantly as a transcriptional repressor (Wang
et al., 2000) while Gli2 works as an activator and is required for
the initiation of Hh signaling (Bai et al., 2002). Target genes of Hh
signaling include Gli1 and Patched 1 (Ptch1) genes, and their
expression has been widely used to assess Hh pathway activity
(Jiang and Hui, 2008).
Hedgehog ligands are secreted proteins that can diffuse
through several cellular diameters (Ingham and McMahon,
2001). In several different tissues, Hh signaling involves Hh-
producing cells, that express and secrete Hh, and Hh-responding
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actions as an important mode of action for this pathway. During
prostate development, Shh secreted by epithelial cells in the
urogenital sinus activates the Hh pathway on adjacent mesench-
ymal cells, which in turn elicit paracrine effects on epithelial
proliferation and differentiation (Yu et al., 2009) and Hh proteins
secreted by the endodermal epithelium during gastrointestinal
tract development act as paracrine mitogens to promote the
expansion of adjacent mesenchyme (Mao et al., 2010).
The critical role of hedgehog signaling in the development and
tissue homeostasis of some epidermal appendages, hair follicle
and teeth, is well established (Ingham and McMahon, 2001).
Several studies have sought to analyze its implication in the
development of the mammary gland, an epidermal appendage
that originates during embryonic life but mainly develops during
puberty and acquires a functional differentiation with the onset
of lactation (Hennighausen and Robinson, 2001). Hh pathway
components, including all three Hh ligands (Gallego et al., 2002;
Kouros-Mehr and Werb, 2006; Lewis et al., 2001; Michno et al.,
2003; Velanovich et al., 1999) and downstream transcription
factors Gli2 and Gli3, are expressed in the mammary tissue
(Hatsell and Cowin, 2006; Lewis et al., 2001). Expression of Hh
transcriptional target genes Gli1 and Ptch1, indicative of pathway
activation, has also been described in the mammary epithelium
and stroma (Gallego et al., 2002; McDermott et al., 2010;
Velanovich et al., 1999) but their expression levels are low and
expression analysis using lacZ-based transcriptional reporter
alleles for both Gli1 and Ptch1 suggested that Hedgehog signaling
might be absent or repressed in mammary cells throughout
development (Hatsell and Cowin, 2006). In addition, we and
others found that Shh and Ihh null embryos display normal
mammary buds that develop normally when transplanted into
cleared fat pads (Gallego et al., 2002; Michno et al., 2003)
although functional redundancy between Hh ligands could
account for the lack of mammary phenotype in these mutants.
Mice lacking functional Gli3 repressor protein show disruption of
embryonic mammary glands formation, supporting the notion
that Hh signaling repression is necessary during early mammary
gland morphogenesis (Hatsell and Frost, 2007). Patch1 gene
haploinsufﬁciency leads to limited Hh pathway activation result-
ing in mammary ductal dysplasias and hyperplasias (Moraes
et al., 2009; Velanovich et al., 1999). In addition, forced ligand-
independent activation of the Hh pathway in the mammary gland
of transgenic mice through the expression of an activated form
of Smoothened also results in ductal hyperplasias and dysplasias
(Moraes et al., 2007; Visbal et al., 2011) and overexpression of
Gli1 in the mammary epithelium of transgenic mice caused
impaired lactation and tumor development (Fiaschi et al., 2009;
Fiaschi et al., 2007). Collectively, these data suggest that, although
Hh pathway repression might be the physiological state in at least
some stages of mammary development, Hh pathway misactiva-
tion in mammary tissue may occur, leading to hyperproliferation
of the epithelial compartment and disturbances of the mammary
structure that are reminiscent of lesions found in human breast
pathologies (Fiaschi et al., 2009; Velanovich et al., 1999).
Inappropriate Hh signaling has been demonstrated in a variety
of tumors (Berman et al., 2003; Karhadkar et al., 2004; Thayer et al.,
2003; Theunissen and de Sauvage, 2009; Watkins et al., 2003) and
remodeling of the tumoral stroma by tumor epithelium-derived
Hh ligands acting on mesenchymal cells, that in turn provide a
more favorable environment for tumor growth, has been proposed
as a commonly occurring cancer-promoting mechanism in a
number of epithelial tumors (Yauch et al., 2008), including human
breast cancer (O’Toole et al., 2011). A mitogenic role for Hh in
mammary stem cell self-renewal and in elaboration of mammary
progenitors has also been described (Li et al., 2008; Liu et al., 2006),suggesting the existence of an intraepithelial Hh signaling mechan-
ism in the mammary tissue, whereby epithelium-derived Hh
ligands might act directly on mammary epithelial progenitor cells.
Unraveling the cellular interactions involved in Hh signaling in the
mammary gland will contribute to the characterization of this
pathway in mammary tumoral pathology.
Recent work reveals that, in vertebrates, Hh signaling is highly
related to the presence of the primary cilium, a microtubule-
containing subcellular organelle that protrudes from the cell sur-
face (Zhang et al., 2009). Functional genetic screens showed that
mutations affecting primary cilia integrity or function in mice
produced patterning defects that resembled Hh-related pheno-
types (Huangfu et al., 2003). Furthermore, Hh pathway compo-
nents are enriched in the cilia, and cilia are necessary for both
activating and repressing functions of Gli proteins (Haycraft et al.,
2005; Huangfu and Anderson, 2005). A role for primary cilia has
recently been described in mammary branching morphogenesis.
Mice bearing a ciliary dysfunction presented decreased ductal
extension and diminished secondary and tertiary branching, along
with reduced lobular-alveolar development during pregnancy and
lactation (McDermott et al., 2010). During mammary development,
primary cilia are found on luminal epithelial, myoepithelial, and
stromal cells in early branching morphogenesis but disappear from
luminal epithelial cells in the mature mammary gland (McDermott
et al., 2010). It remains to be studied whether this distribution
reﬂects the location of Hh-responsive cells in this organ.
We have sought to analyze Hh pathway signaling in the
mammary epithelium, trying to determine which cells are
responsive to Hh ligands, and what are the effects on the
mammary tissue when the pathway is activated in the mouse
mammary gland employing a ligand-driven Hh pathway activa-
tion transgenic model.Materials and methods
Generation of WAP-Shh transgenic mice
The mouse Shh cDNA (a gift from Dr. Phil Beachy, Stanford
University) was cloned in an expression vector containing a 1.6 kb
fragment of the mouse WAP (whey acidic protein) gene promoter
sequence, the second intron of rabbit b-globin gene and rabbit
b-globin gene and SV40 polyadenylation sequences (Gallego et al.,
2003). Transgenic mice were generated by microinjection of this
construct into C57Bl/6JxDBA/2J F2 embryos using standard tech-
niques. Transgenic founders were identiﬁed by Southern blot
analysis of tail genomic DNA using mouse Shh cDNA as a probe
(not shown). Transgenic offspring were subsequently identiﬁed
by PCR using primers ShhTg F: 50-CGT GCT GGT TAT TGT GCT
GTC-30 and ShhTg R: 50-CCA CTG GTT CAT CAC AGA GAT G-30
amplifying a fragment of 400 pb. Transgenic lines were estab-
lished in the FVB genetic background by backcrossing for at least
eight generations and same age and parity FVB wild type control
littermates were used as control mice.
Knock-in mice carrying the Ptch1 targeted disruption and lacZ
marker allele (Goodrich et al., 1997) herein designated as Ptch1-
lacZ, were obtained from Jackson Lab and maintained in a C57BL/
6J genetic background. PCR genotyping for this allele was carried
out as described (Goodrich et al., 1997). Mammary samples for
analysis were obtained from the offspring of WAP-Shh mice in the
FVB background and Ptch1-lacZ mice in C57BL/6J background.
WAP-Shh/Ptch1-lacZ bitransgenic and Ptch1-lacZ only, same age
and parity, control mammary tissues were analyzed. All experi-
mental procedures were performed according to the European
and Spanish laws and regulations and approved by our institu-
tion’s ethics committee.
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Total RNA was isolated and Northern blots were performed as
described previously (Robinson et al., 1995). The whole mouse
Shh cDNA and fragments from mouse Ptch1 and WAP cDNAs
were used as probes.
Histology, immunoﬂuorescence and immunohistochemistry
Mammary tissue was harvested from recently euthanized
mice. For whole mount examination, mammary tissues were
ﬁxed in Carnoy’s solution and stained with carmine aluminum
overnight as described previously (Kordon et al., 1995). For
histological analysis, 5 mm parafﬁn sections were stained with
H&E. For immunoﬂuorescence, tissues were ﬁxed with formalin
and processed by standard protocols. 5 mm parafﬁn sections
were deparafﬁnized and boiled in microwave oven in 10 mM
Sodium Citrate Buffer, incubated overnight with primary anti-
bodies followed by 1 h incubation with appropriate secondary
antibodies.
Slides were observed using an Axio Imager A1 ﬂuorescence
microscope (Carl Zeiss AG, Oberkochen, Germany) or a Leica
TCS SP5 AOBS Confocal Microscope (Leica Microsystems GmbH,
Wetzlar, Germany) for cilia immunoﬂuorescence visualization.
Primary antibodies used for immunohistochemistry and
immunoﬂuorescence analysis are: Integrin Beta 3 (ITGB3) rabbit
monoclonal (ab75872 Abcam) 1/100 dillution; Collagen IV
(Col IV) rabbit polyclonal (ab6586 Abcam) 1/100; Collagen I
(Col I) rabbit polyclonal (ab292 Abcam) 1/100 diluted; Cytoker-
atin 5 (K5) rabbit polyclonal (AF 138, Covance) 1/200 dilution;
Cytokeratin 6 (K6) rabbit polyclonal (PRB-169P Covance) 1/100
dilution; Cytokeratin 14 (K14) rabbit polyclonal (AF64, Covance)
1/200 dilution; Cytokeratin 15 (K15) mouse monoclonal (LHK15,
Thermo Fisher Scientiﬁc) 1/100 dilution; Cytokeratin 17 (K17)
rabbit polyclonal (ab53707, Abcam) 1/100 dilution; Gli2 rabbit
polyclonal (ab26056, Abcam) 1/100 dilution, Cytokeratin 8 (K8)
rat monoclonal Troma I supernatant (Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA); p63 mouse
monoclonal (clone 4A4, Santa Cruz ) 1/20 dilution; PCNA mouse
monoclonal (PC10, Abcam) 1/500 dilution; Sonic hedgehog (Shh)
rat monoclonal (clone171018, Abcam) 1/20 dilution; Sonic–
Indian hedgehog (Shh/Ihh) rabbit polyclonal (2271, Cell Signaling)
1/50 dilution; Acetylated tubulin(ac-Tub) mouse monoclonal
(clone 6-11B-1, Sigma-Aldrich) 1/1000 dilution; Beta galactosi-
dase (b-gal) rabbit polyclonal (55976, Cappel) 1/250 dilution;
Gamma-tubulin (g-Tub) rabbit polyclonal ( T5192, Sigma-Aldrich)
1/1000 dilution; b-catenin (b-cat) mouse monoclonal (clone 14,
BD Transduction Laboratories) 1:100 dilution; Smooth muscle
actin (SMA) clone 1A4 –FITC conjugate mouse monoclonal
(Sigma-Aldrich) 1/250 dilution.
Immunohistochemical analysis of beta-galactosidase expres-
sion was performed with the same tissue ﬁxation, deparafﬁniza-
tion and antigen retrieval protocols as in the immunoﬂuorescence
analysis. However, a subsequent treatment of the tissue slides
with hydrogen peroxide was needed to eliminate endogenous
peroxidase activity. Serum blocking and overnight primary anti-
body incubation was followed by 1 h incubation with the appro-
priate HRP-conjugated secondary antibody and 30 min with
Vectastain ABC reagent (as per kit instructions). The slides were
incubated for 2 min with the DAB developing solution and
counterstained with hematoxylin.
Quantitative RT-PCR assays
First or second lactation, number 4 mammary glands (after
lymph node removal) from lactating day 1 female mice were usedfor RNA extractions. Glands from three different animals were
used for each time point. Total RNA was isolated using Trizol
Reagent (Invitrogen) according to the manufacturer’s instructions,
and treated with DNA-Free RNA Kit (Zymo Research). cDNA was
reverse transcribed from 2 mg of RNA using AMV Reverse Tran-
scriptase (Promega). b-actin was used as internal control. Primers
used for b-actin were: actinF 50-TGT TAC CAA CTG GGA CGA CA-30,
actinR 50-GGG GTG TTG AAG GTC TCA AA-30; for Shh: ShhL 50-ACC
CCG ACA TCA TAT TTA AGG A-30, ShhR 50-TTA ACT TGT CTT TGC
ACC TCT GA-30; for Ptch1: Ptch1L 50-GGA AGG GGC AAA GCT ACA
GT-30, Ptch1R 50-TCC ACC GTA AAG GAG GCT TA-30; for Gli1: Gli1L
50-CTG ACT GTG CCC GAG AGT G-30, Gli1R 50-CGC TGC TGC AAG
AGG ACT-30; for Gli2: Gli2L 50-GCA GAC TGC ACC AAG GAG TA-30,
Gli2R 50-CGT GGA TGT GTT CAT TGT TGA-30. Real-time PCR was
performed using the reverse transcription product as template
with the GoTaq qPCR Master Mix (Promega) according to the
manufacturer’s instructions. Ampliﬁcations were carried out in
a Light Cycler 2.0 (Roche) using the following cycles: 2 min 95 1C,
40 cycles (15 s 95 1C, 1 min 60 1C), 7 min 60 1C. The PCR products
quality was checked by a melting curve analysis. Relative quanti-
ﬁcation of gene expression analysis was performed using the
Pfafﬂ method (Pfafﬂ, 2001>).
Statistics
Statistical analysis was performed with Graph Pad Prism,
Version 5 (Graph Pad software, Inc.). The t-test with Welch’s
correction was used for unpaired data. Statistical signiﬁcance was
established at npo0.05, nnpo0.01 and nnnpo0.001.
1.1. Whole-mount X-gal staining of transgenic mice
For whole-mount X-gal staining, Ptch1-lacZ and WAP-Shh/
Ptch1-lacZ lactating females were used. Mammary glands from
three different animals were taken for each analysis. Number
3 mammary glands were harvested on day 1 of lactation, and
ﬁxed for 2 h in 2% paraformaldehyde, 0.25% glutaraldehyde, 0.01%
NP-40 in PBS. After rinsing in PBS, glands were incubated for 2 h
in pre-staining buffer, containing 2 mM MgCl2, 0.01% Na-deox-
ycholate, 0.02% NP-40 in PBS. Then, glands were incubated at
25 1C overnight in staining buffer containing 30 mM potassium
ferricyanide, 30 mM potassium ferrocyanide, 2 mM MgCl2, 0.01%
Na-deoxycholate, 0.02% NP-40, and 1 mg/ml X-gal in PBS. After
that, half of glands were ﬁxed in 4% paraformaldehyde and
mounted in Permount. The other half were dehydrated and
embedded in parafﬁn for sections, and stained with eosine.Results
Generation of WAP-Shh transgenic mice
To facilitate the analysis of Hh signaling in mammary gland
we generated transgenic mice expressing Shh under the control of
the parity-inducible, mammary-speciﬁc WAP gene promoter.
Nine transgenic founder mice were identiﬁed by Southern blot
analysis of DNA samples from mice obtained after pronuclear
injection of one-cell C57Bl/6JxDBA/2J F2 embryos, using a frag-
ment of the transgene as a probe. Northern blot analysis showed
expression of transgenic Shh mRNA in lactating mammary glands
from lactation day 1 (L1) primiparous transgenic mice of two
different lines: 119 and 186 (Fig. 1A, lanes 2 and 4). Shh
expression levels in these whole-organ samples were comparable
to those found in embryonic E15 brain tissue, included in the
Northern blot as a positive control (Fig. 1A, lane 12). Endogenous
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Fig. 1. Transgenic Shh expression analysis. (A) Upper panel: total RNA Northern blot analysis of Shh expression. First lactation day 1 (L1) lactating mammary tissues from
transgenic lines (1–5, 7, 9–11), and wild type controls (6, 8). Wild type fetal brain E15 (positive control; 12). Lower panel: membrane reprobed with WAP as a loading
control. Similar expression levels were found in all 11 samples corresponding to lactating glands (1–11). No band was detected in fetal brain control sample (12). (B) RT-
qPCR analysis of Shh, Ptch1 and Gli1expression in 119 and 186 WAP-Shh transgenic lines and wild-type lactating mammary gland samples. 92729 and 44725 fold
inductions of Shh expression, 973.8 and 4.571.0 fold inductions of Ptch1 expression and 10.574.5 and 5.571.6 fold inductions of Gli1 expression, relative to wild type
glands (WT) is found in samples from line 186 and 119 respectively. (C and D) Immunoﬂuorescence analysis of Hedgehog protein expression using a polyclonal antibody
that detects both Ihh and Shh proteins (Shh/Ihh) in WAP-Shh (D) and wild type control (C) mammary tissue samples. (E and F) Keratin 5 (K5) in WAP-Shh (F) and wild type
control (E) L1 mammary tissue samples. DAPI stained nuclei (blue). (G and H) Whole-mount analysis of 12 month-old multiparous (four lactations), involuted, mammary
glands. Carmine aluminum-stained wild type (G) and WAP-Shh (H) mammary ducts from mammary gland number four. The ﬁgures show dilated ducts near the lymph
node (LN) area in the WAP-Shh sample as compared to wild type control.
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type lactating control tissue (lanes 6 and 8).
Shh overexpression in lactating WAP-Shh transgenic tissue, as
compared to physiological levels in control glands, was quantiﬁed
by RT-qPCR analysis using samples from transgenic lines 119
and 186. We found 92729 and 44725 fold inductions of Shhexpression, relative to wild type glands, in samples from line 186
and 119 respectively (Fig. 1B). Hedgehog protein expression in
transgenic glands was analyzed by immunoﬂuorescence staining
using a rabbit polyclonal antibody that detects both Shh and Ihh
proteins. Bright granular staining was found in the secretory
epithelium of WAP-Shh transgenic glands (Fig. 1D, arrow), but
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Shh-expressing lines (henceforth referred to as WAP-Shh mice)
were used in subsequent experiments.
To assess the extent of Hh pathway activation in transgenic
mammary glands, we analyzed the expression of Ptch1 and Gli1,
both Hh target genes and well-established indicators of pathway
activity. RT-qPCR experiments showed Ptch1 and Gli1 induction
in the two transgenic lines. Ptch1 induction was 973.8 and
4.571.0 fold, relative to wild type mammary glands, and Gli1
induction was 10.574.5 and 5.571.6, in samples from lines 186
and 119 respectively (Fig. 1B). These data prove at a molecular
level the activation of the Hh pathway in WAP-Shh mammary
glands.
The overall structure of the mammary glands was analyzed
by preparing whole-mount stainings of WAP-Shh and control
littermate samples. Morphological abnormalities consisting of
ductal dysplasias and ectasia in not lactating mammary glands
from multiparous (four lactation cycles) mice were obvious in
WAP-Shh samples (Fig. 1H) but not in wild type (WT) same parity
control littermates (Fig. 1G). These phenotypic alterations were
suggestive of the presence of a cellular population in which
activation of the Hh pathway in response to transgenic Shh
expression resulted in altered growth or differentiation. In addi-
tion, immunoﬂuorescence analysis of basal cell marker keratin
5 showed remarkably increased expression in transgenic (Fig. 1F)
as compared to control lactating mammary gland sections
(Fig. 1E), also suggesting altered mammary gland differentiation.
Although a fraction of aging (older than 18 months) WAP-Shh
mice in the FVB genetic background developed mammary tumors,
a similar incidence of mammary tumorigenesis was found in non-
transgenic control littermates. It has been previously described
that spontaneous tumorigenesis occurs in mammary tissue of
aging FVB mice (Radaelli et al., 2009). However, no mammary
tumors were found when WAP-Shh mice where bred into other
genetic backgrounds (DBA/2) or into the hybrid background
in which our model is established (FVB x C57Bl/6) F1. For this
reason, we did not characterize WAP-Shh tumors further.Detection of Hh responsive cells in the mammary tissue of WAP-Shh
mice
To detect Hh responsive cells, we analyzed the Hedgehog
pathway activity in the mammary tissue in situ by generating
mice that carry both the WAP-Shh transgene and a Patched 1-lacZ
reporter allele (Ptch1-lacZ), in which the expression of a nuclear-
targeted b-gal protein is driven by the endogenous Ptch1 gene
regulatory region (Goodrich et al., 1997). This marker knock-in
allele is also null for the Ptch1 gene and results, in itself, in limited
activation of the Hh pathway due to Ptch1 haploinsufﬁciency
(Lewis et al., 1999). To obtain these double transgenic mice, we
bred WAP-Shh transgenic mice, previously backcrossed into the
FVB genetic background, with Ptch1-lacZ mice in C57Bl/6J genetic
background. F1 offspring female mice were used for mammary
gland analysis. b-gal activity was analyzed at lactation day 1(L1)
to allow for highest WAP promoter expression. Mammary whole-
mount X-gal staining revealed some limited, scattered areas with
detectable b-gal activity in WAP-Shh/Ptch1-lacZ samples from
ﬁrst lactation, but staining was more widespread and readily
detectable in second lactation samples (Fig. 2C, arrow). Consis-
tently, RT-qPCR analysis allowed us to quantify in 2.57 0.4 and
2.57 0.2 fold the increase of Ptch1 expression between second
and ﬁrst lactation, in lines 186 and 119 respectively (Fig. 2A).
Sections of X-gal staining are shown in Fig. 2D–G. No staining was
found in Ptch1-lacZ control littermates mammary sample pre-
parations (Fig. 2B and D).Immunohistochemical detection of the b-gal protein was
performed to identify the Hh-responsive cells in parafﬁn sections
of WAP-Shh/Ptch1-lacZ lactating mammary tissues. We detected
clusters of mammary epithelial cells strongly immunoreactive for
b-gal protein with a distinct nuclear staining pattern, revealing
the sites where the Hh pathway was active (Fig. 2H, magniﬁed in
I, black arrow). The rest of mammary epithelial cells in the gland
presented a faint immunostaining for b-gal (Fig. 2I, blue arrow)
while the stroma was clearly negative (Fig. 2I, red arrow). No
immunostaining for b-gal was found in mammary tissue from
control mice not carrying the lacZ allele (not shown).
b-gal positive cells were found preferentially in a basal loca-
tion in dysplastic areas of ducts and lobules. Despite their basal
location, these Ptch1-expressing cells did not have the ﬂat
appearance of bona ﬁde myoepithelium, resembling a cuboidal
epithelium instead (Fig. 2I, black arrow).
To analyze the correlation between transgenic Shh expression
and Hh-responding cells, we performed double immunoﬂuores-
cence staining in parafﬁn sections of lactating mammary
glands from WAP-Shh/Ptch1-lacZ bitransgenic and Ptch1-lacZ
control mice to simultaneously detect b-gal and Shh proteins.
Using a monoclonal antibody that speciﬁcally detects Shh, we
observed areas of robust Shh staining in mammary luminal cells
of bitransgenic mice, as expected for a WAP-driven transgenic
protein (Fig. 2K, arrow). Noteworthy, b-gal staining, revealing
endogenous Ptch1 expression, was found exclusively in adjacent,
basally located cells, but not in the luminal, WAP-expressing cells
where the Shh transgene is expressed. No staining was found for
Shh or b-gal in Ptch1-lacZ control tissue (Fig. 2J).
To characterize these Hedgehog target cells in the mammary
tissue, we simultaneously analyzed keratin 8 (K8), a marker for
luminal cells, and b-gal expression. b-gal-expressing cells did not
express K8, conﬁrming their non-luminal identity (Fig. 2M), and
were arranged as a single layer, occasionally multilayer, of cells
placed in a basal location with respect to keratin 8-positive
luminal cells (Fig. 2M, white arrow). The apparent occasional
detection of K8 in sections of multilayered basal epithelium
(Fig. 2M, yellow arrow) is in fact produced by K8 expression in
a lower plane, and can be observed because b-gal-positive cells
are small and do not form a continuous layer. No staining for
b-gal was found in Ptch1-lacZ control samples (Fig. 2L).
We conﬁrmed the luminal identity of Hh-expressing cells in
our model by double Shh-Ihh/K8 immunoﬂuorescence analysis of
WAP-Shh/Ptch1-lacZ and Ptch1-lacZ control lactating mammary
tissues. We detected strong Hh expression in luminal (K8 positive
cells) in WAP-Shh/Ptch1-lacZ as compared to faint expression in
Ptch1-lacZ control lactating mammary glands (supplementary
Fig. S1).
These data point to a paracrine mode of action where Shh
protein, secreted by luminal epithelium, induces Ptch1 expres-
sion, and therefore Hh pathway activation, in adjacent cells, but
not in the Shh-producing cells themselves.
Hh-responsive cells overexpressed basal markers and lacked SMA
expression
Since Ptch1-expressing, b-gal positive cells were located in a
basal position, we decided to analyze whether they expressed
mammary myoepithelial cell markers keratin 5 (K5), keratin 14
(K14), keratin 17 (K17), p63 and smooth muscle actin (SMA).
Double staining showed that b-gal expression and high expres-
sion levels of p63 co-localized in the dysplastic areas found in
WAP-Shh/Ptch1-lacZ mammary tissue (Fig. 3F), while normal
myoepithelial cells found in Ptch1-lacZ control samples displayed
low p63 staining and did not present detectable b-gal staining
(Fig. 3C, arrow). Double immunoﬂuorescence analysis for basal
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control (D). (H) Immunohistochemical analysis of b-gal protein on a parafﬁn section of a second lactation mammary tissue sample from a WAP-Shh/Ptch1-lacZ mouse.
b-gal-positive alveoli (brown nuclei) can be observed near a wide duct (lumen). (I) Higher magniﬁcation of the same area. b-gal-positive cells constitute the outer layer of
dysplastic alveoli (black arrow). Faint b-gal staining (blue arrow) in non-dysplastic alveoli. Stromal cells are b-gal-negative (red arrow). (J and K) b-gal/Shh
immunoﬂuorescence detection in a WAP-Shh/Ptch1-lacZ dysplastic (K) and Ptch1-lacZ control (J) mammary tissues taken from fourth lactation day 3 mammary glands.
A continuous monolayer, occasionally multilayer, of b-gal-positive cells in a basal location (K, red nuclei) and strong Shh staining in some of the luminal cells neighboring
b-gal-positive cells (K, arrow) are shown. b-gal and Shh are not detectable in Ptch1-lacZ control tissue (J). (L and M) b-gal/K8 immunoﬂuorescence analysis of sections from
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mammary epithelium (F). (G–L) Overexpression of p63 and K5, K14 and K17 keratins in WAP-Shh/Ptch1-lacZ basal hyperplasias (J–L, arrows) and co-expression but no
overexpression in Ptch1-lacZ control myoepithelium (G-I, arrows). (a-p63 mouse monoclonal antibody yielded some non-speciﬁc cytoplasmic and extracellular staining).
(N–P) b-gal/SMA (M and O) and K14/SMA (N and P) expression in Ptch1-lacZ control and dysplastic lesions in WAP-Shh/Ptch1-lacZ samples. b-gal positive (O) and K14-
overexpressing basal epithelial cells (P) in WAP-Shh/Ptch1-lacZ dysplastic lesions do not express SMA (O and P, white arrows). SMA is readily detectable in WAP-Shh/
Ptch1-lacZ normal alveoli (P, yellow arrow) or Ptch1-lacZ control mammary tissues (M and N). The asterisks in M marks a b-gal positive nuclei in a perineural ﬁbroblasts at
a peripheral nerve. (Q) Basal to luminal cell ratio in fourth lactation WAP-Shh/ Ptch1-lacZ dysplastic and Ptch1-lacZ control mammary tissues. A 10-fold expansion of the
basal compartment was found in WAP-Shh/ Ptch1-lacZ Hh-signaling areas: 2.6570.5 basal/luminal ratios in WAP-Shh/Ptch1-lacZ dysplastic areas vs. 0.2870.06 basal/
luminal ratio in lactating Ptch1-lacZ control tissue (po0.001).
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p63 also overexpressed K5, K14 and K17 in WAP-Shh/Ptch1-lacZ
mice (Fig. 3J–L) therefore implying that overexpression of basal
keratins correlated with Ptch1 expression. We could not directly
perform double staining for b-gal and basal layer keratins since all
available antibodies amenable to this staining strategy were
produced in rabbit. Ptch1-expressing cells in dysplastic areas
were therefore characterized by very high expression of basal
markers and a cuboidal morphology, clearly differentiating them
from ﬂat-shaped myoepithelial cells that also expressed basal
keratins, albeit at much lower levels (Fig. 3G–I).
We next performed double immunoﬂuorescence analysis to
study the presence of smooth muscle actin (SMA) in b-gal-positive
cells. In contrast to the basal markers tested previously, SMA
was totally absent from the dysplastic regions, showing the fact
that b-gal and SMA expression were mutually exclusive (Fig. 3O,
arrow). Consistently, double immunostaining for SMA and K14
showed absence of SMA expression in K14-overexpressing cells in
basal hyperplasias found in WAP-Shh/Ptch1-lacZ mammary glands
(Fig. 3P, white arrow and supplementary Fig. S2A, arrow) but not in
normal myoepithelial cells present in WAP-Shh/Ptch1-lacZ (Fig. 3P,
yellow arrow) or Ptch1-lacZ mammary myoepithelium (Fig. 3N).
We also demonstrated that K14 overexpressing cells do not
express luminal marker K8 (Supplementary Fig. S2B, arrow).
Additional panels showing more extended areas of the dys-
plastic basal epithelium are shown in supplementary Fig. S3B–D.
In addition to the increased expression of basal markers in
the Hh-responsive cells, we found a signiﬁcant increase of the
basal to luminal cell ratio in WAP-Shh/Ptch1-lacZ Hh-signaling
areas (2.6570.5) compared to normal lactating Ptch1-lacZ con-
trol tissue (0.2870.06; po0.001). This 9.5 fold increase of basal
compartment suggests that basal cell hyperplasia is in the origin
of WAP-Shh/Ptch1-lacZ mammary glands dysplasias. Despite the
presence of basal hyperplasia and dysplasias, no mammary
tumors were found in WAP-Shh/Ptch1-lacZ mice, or in non-
transgenic littermates, in this genetic background.Hedgehog pathway activation caused morphological alterations
of mammary tissues
Histological analysis of lactating mammary tissues from
WAP-Shh/Ptch1-lacZ bitransgenic mice revealed dysplastic areas
extending along ducts and lobules (Fig. 4B, magniﬁed in D).
No morphological alterations were apparent at this stage in
Ptch1-lacZ control littermates glands (Fig. 4A). The dysplastic
areas presented scarce lobulo-alveolar structures some of which
contained an intensely stained secretion (Fig. 4B, black arrow)
different from the milk shown in control lactating Ptch1-lacZ
tissue (Fig. 4A, black arrow). Protruding from ducts, there were
solid hemispherical structures composed of small round cells
with clear nucleoplasm (Fig. 4D, green arrow). b-gal immuno-
ﬂuorescence analysis of the same area shown in Fig. 4B, showed
positive b-gal nuclear staining in all cuboidal-shaped basal layer
cells (Fig. 4C, yellow arrow) as well as in the cells that formed the
characteristic solid structures (Fig. 4C white arrow), demonstrat-
ing the coincidence of Hh pathway activation with dysplastic
areas.
We examined Wnt pathway activation in dysplastic areas
since activation of this pathway by Hh signaling has been shown
in other organs (Shin et al., 2011) and Wnt activation is com-
monly associated with dysplastic lesions in mouse mammary
tumor models (Gallego et al., 2003; Miyoshi et al., 2002). Double
immunoﬂuorescence staining for b-catenin and b-gal showed
that b-catenin was localized exclusively at the cellular membrane,
and not in the cytoplasm or nuclei, in Shh-responding or adjacentcells (Fig. 4C), indicating that the Wnt pathway is not active in
Hh-driven mammary lesions.
In addition to the epithelial changes found in Hh-responsive
areas, a thicker stroma was observed around the hyperplastic
structures (Fig. 4B, blue arrow), as compared to stroma near
normal alveoli (Fig. 4A, blue arrow). Double immunoﬂuorescence
detection of collagen I (Col I), a main component of the extra-
cellular matrix, and myoepithelium marker SMA, showed
increased Col I deposition around Hh-associated hyperplasias,
identiﬁed by the absence of SMA expression (Fig. 4F, white arrow)
as compared to the thin Col-1 deposition around normal alveoli in
Ptch1-lacZ lactating tissue (Fig. 4E arrow). Some Col I could be
detected between the epithelial cells of the hyperplasia (Fig. 4F,
yellow arrow). This suggests that hyperplastic basal layer cells are
not forming a continuous layer.
Expression of collagen IV, a component of the basement
membrane produced and secreted by myoepithelial and
mesenchymal cells (Warburton et al., 1986) was analyzed to
further characterize Hh-responding cells. Double immunoﬂuor-
escence detection of collagen IV and p63, a surrogate marker of
Hh activation in our model, showed that while in normal ducts
and alveoli, found in Ptch1-lacZ control littermates mammary
glands, collagen IV was localized at the basement membrane
forming a lamina between the epithelium and the stroma
(Fig. 4G), in hyperplastic ducts and lobules of WAP-Shh/Ptch1-
lacZ mammary glands, Col IV is overexpressed and it comple-
tely encircled p63-overexpressing cells (Fig. 4H, arrow). This
pattern of collagen IV deposition is further proof of the altered
differentiation caused by Hh activation in basal mammary
epithelial cells.
Nuclear localization of Gli2 protein in Hh-responding cells and
increased expression of Gli1 and Gli2 genes in WAP-Shh/Ptch1-lacZ
mammary tissue
To further characterize Hh pathway activation in the
hyperplastic regions adjacent to Shh-expressing cells found in
bitransgenic mammary tissue, we performed double immuno-
ﬂuorescence staining for p63 and Gli2 transcription factor, the
initial executor of Hh-induced transcriptional activation. We
found nuclear Gli2 staining in p63-overexpressing cells
(Fig. 5D–F) while only cytoplasmic staining was detected in
control Ptch1-lacZ lactating tissue samples (Fig. 5B). These data
show functional activation of the Hh pathway in the basal cell
hyperplastic areas.
To quantitatively assess pathway induction in transgenic
tissues, we performed RT-qPCR analysis of Gli1 and Gli2 expres-
sion. We found that both Gli1 and Gli2 transcripts were induced
in WAP-Shh/Ptch1-lacZ lactating mammary tissues as compared
to wild type controls (Fig. 5G). Gli1showed fold inductions
21.273.8 and 6.770.3 relative to wild type samples, in lines
186 and 119 respectively and Gli2 showed fold inductions
20.5712.0 and 6.272.0 relative to wild type samples, in lines
186 and 119, respectively. Some induction of Gli1 and Gli2 was
also found for Ptch1-lacZ control tissues relative to wild type
samples, although at remarkably lower levels than in the double
transgenic tissues (2.7570.1 fold induction for Gli1 and 4.671.1
fold induction for Gli2 (Fig. 5G)).
Expression of mammary progenitor cell markers in the hyperplastic
basal compartment of WAP-Shh/Ptch1-lacZ mammary glands
Mammary progenitor and stem cells have been characterized
by their integrin receptors expression pattern (Shackleton et al.,
2006; Stingl et al., 2006). Speciﬁcally, integrin b3 (Itgb3), has been
identiﬁed as a marker for the luminal progenitor compartment
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Fig. 4. Hedgehog pathway activation causes morphological alterations in WAP-Shh/Ptch1-lacZ mammary tissues. Histological and immunoﬂuorescence analysis of fourth
lactation mammary tissue samples. (A and B ) Histological analysis of Ptch1-lacZ control (A) and dysplastic WAP-Shh/Ptch1-lacZ (B) mammary samples. Lactating tissue
displays expanded lobulo-alveolar structures ﬁlled with milk (A, black arrow) surrounded by mammary fat-pad (A, blue arrow). Altered lobulo-alveolar structure
containing intensely stained secretion different from milk (B, black arrow) and spherical solid structures surrounded by a thick stroma (B, blue arrow). (C) b-gal/b-catenin
immunoﬂuorescence detection of the same area as shown in B. b-gal-positive cells are present in solid spherical structures (white arrow) and abnormal cuboidal-shaped
basal epithelium (yellow arrow). b-catenin is detected exclusively at the cell membrane both in b-gal positive and negative cells. (D) A higher magniﬁcation of the
histological preparation shown in B (highlighted area). Cuboidal-shaped basal epithelium (black arrow) and abnormal spherical solid epithelial structure (green arrow).
The stroma is thick around hyperplastic structures. (E and F) Confocal laser scanning immunoﬂuorescence detection of Collagen I (Col I) in Ptch1-lacZ control tissue (E) and
WAP-Shh/Ptch1-lacZ hyperplasias (F). Col I/SMA immunoﬂuorescence detection showing normal expanded alveoli expressing SMA and surrounded by a thin layer of Col I
(E, arrow). Hyperplastic structures lacking SMA expression surrounded by a thicker layer of Col I (F, white arrow). Col I expression between hyperplastic epithelial cells
(4F, yellow arrow). (G and H) p63/Col IV detection showing Ptch1-lacZ control (G) and WAP-Shh/Ptch1-lacZ hyperplastic (H) ducts. Collagen IV is located at the basement
membrane in G (arrow) and it is overexpressed and encircles p63-overexpressing cells in H (arrow).
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b3 in WAP-Shh/Ptch1-lacZ and Ptch1-lacZ control mammary
tissue sections by performing double immunoﬂuorescence stain-
ing for integrin b3 and p63 (a marker for Hh-responsiveness
in our model). Normal, non-hyperplastic areas of transgeniclactating tissue and wild type control displayed integrin b3
staining only in isolated cells, most of which did not express
p63 (Fig. 6A, arrow). A different expression pattern was found
in the hyperplastic areas of bitransgenic mammary tissue, where
abundant integrin b3 expression was detected in clusters of
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Fig. 5. Nuclear localization of Gli2 protein in Hh-responding cells and increased expression of Gli1 and Gli2 genes in WAP-Shh/Ptch1-lacZ mammary tissue. (A–F) p63/Gli2
immunoﬂuorescence analysis of parafﬁn sections from fourth lactation of Ptch1-lacZ control (A–C) and hyperplastic WAP-Shh/Ptch1-lacZ (D–F) mammary tissue: p63
expression in the nuclei of hyperplastic basal epithelium (D); Gli2 nuclear localization in hyperplastic basal epithelium (E); p63 and Gli2 nuclear colocalization (F). (G) RT-
qPCR analysis of Gli1 (left) and Gli2 (right) expression in wild-type (WT), Ptch1-lacZ control, 119 and 186 WAP-Shh/Ptch1-lacZ transgenic lines lactating tissue. Gli1shows
fold inductions 21.273.8 and 6.770.3 and Gli2 shows fold inductions 20.5712.0 and 6.272.0 in lines 186 and 119 relative to WT tissue samples. A fold induction
2.7570.1 for Gli1 and 4.671.1 fold induction for Gli2 expression is found for Ptch1-lacZ control tissues relative to WT samples. Lower panels: Gli1 and Gli2 RT-PCR
products (ethidium bromide-stained agarose gel).
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of the percentage of integrin b3 positive cells revealed a 55-fold
increase in the number of cells expressing this progenitor cell
marker in dysplastic areas of lactating WAP-Shh/Ptch1-lacZ
mammary tissue, relative to lactating Ptch1-lacZ control tissue
(2871.2% vs. 0.570.02%; Fig. 6G).
Expression of another luminal progenitor marker, keratin 15
(K15), not usually present in normal mouse mammary tissues
(Mikaelian et al., 2006), was also found in clusters in Hh-
responsive, b-gal positive cells (Fig. 6E, arrow), while only weak
and scattered K15 staining could be found in Ptch1-lacZ control
(Fig. 6B, arrow).Clusters of integrin b3-expressing cells were more abundant
and overlapped to some extent, but not completely, with cells
expressing keratin 15 in WAP-Shh/Ptch1-lacZ dysplastic areas
(Fig. 6H, arrow).
Expression of keratin 6 (K6), that is only expressed at sig-
niﬁcant levels in the mouse mammary gland during pregnancy,
but not during lactation, and is also considered a progenitor cell
marker (Smith et al., 1990), was occasionally found in discrete
clusters of cells (2–8 cells) adjacent to K15-expressing cells
(Fig. 6F, arrow) in WAP-Shh/Ptch1-lacZ dysplastic areas, while
it was absent in Ptch1-lacZ control samples (Fig. 6C). These
K6-positive cells were p63-negative, suggesting that K6 expression
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Fig. 6. Progenitor cell markers expression in dysplastic areas of WAP-Shh/Ptch1-lacZ lactating mammary glands. (A–F, H and I) Progenitor cell markers immunoﬂuor-
escence detection in Ptch1-lacZ (A–C) and WAP-Shh/Ptch1-lacZ dysplastic (D–F, H and I) second (A and D) or fourth lactation (B, C, E, F, H and I) mammary tissues. (A and
D) p63/integrin b3 staining: integrin b3 (Itgb3) is detected in scarce, isolated, p63 negative, luminal cells in Ptch1-lacZ control samples (A, arrow) and abundant integrin b3
expression is found in clusters of p63-positive cells in WAP-Shh/Ptch1-lacZ dysplastic regions (D, arrow). (B and E) K15/b-gal staining: b-gal-negative cells in Ptch1-lacZ
control samples display weak and scattered K15 staining (B, arrow) and K15 expression is readily detectable in clusters of b-gal-positive cells in WAP-Shh/Ptch1-lacZ
dysplastic regions (E, arrow a-K15 mouse monoclonal antibody yielded some non-speciﬁc stromal staining ). (C and F) K15/K6 staining: K6 expression is absent in Ptch1-
lacZ control samples (C) and K6-expressing cells adjacent to K15-expressing cells in WAP-Shh/Ptch1-lacZ dysplastic region (F, arrow). (G) Percentage of integrin b3 cells in
Ptch1-lacZ mammary tissue and WAP-Shh/Ptch1-lacZ mammary hyperplasias at lactation day 3 showing a 55-fold increase in Itgb3 (þ) cells in dysplastic areas of
lactating WAP-Shh/Ptch1-lacZ mammary tissue, relative to lactating Ptch1-lacZ control tissue (2871.2% vs. 0.570.02%). H) integrin b3/K15 expression. Integrin b3-
expressing and K15-expressing cells partially overlap in a limited co-expression area (arrow). (I) p63 and K6 staining: K6 expression is found in scarce luminal cells that do
not express p63 but are adjacent to p63-overexpressing cells (arrow).
E. Garcı´a-Zaragoza et al. / Developmental Biology 372 (2012) 28–4438is not a direct target of the Hh pathway, but might be induced in
cells adjacent to Hh-responding cells (Fig. 6I, arrow).
Hh-responding cells in WAP-Shh/Ptch1-lacZ dysplastic areas present
a low proliferation rate
Immunoﬂuorescence staining for PCNA showed a lower prolif-
eration rate in WAP-Shh/Ptch1-lacZ Hh-signaling areas, revealedby b-gal and basal marker K14 overexpression (Fig. 7F, H), as
compared to proliferation in Ptch1-lacZ control tissue (Fig. 7E, G). A
two fold decrease in PCNA incorporation was found in WAP-Shh/
Ptch1-lacZ Hh-signaling areas than in Ptch1-lacZ control lactating
tissue. (5.2%70.9781 vs. 10.76%70.5367; Fig. 7A). Furthermore,
within the dysplastic region PCNA incorporation was ﬁve times
lower in Hh-responsive, b-gal(þ) cells, than in adjacent b-gal()
cells. The PCNA(þ) b-gal() cells/PCNA(þ)b-gal(þ) cell ratio was
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Fig. 7. Hh-responsive cells in WAP-Shh/Ptch1-lacZ dysplastic areas present a low proliferation rate. (A) Percentage of PCNA incorporation in Ptch1-lacZ control and WAP-
Shh/Ptch1-lacZ dysplastic areas from fourth lactation mammary tissues. PCNA incorporation rate is 5.270.97815% in WAP-Shh/Ptch1-lacZ dysplastic regions vs.
10.7670.5367% in Ptch1-lacZ control tissue. (B) PCNA(þ)/ b-gal() to PCNA(þ)/b-gal(þ) cell ratio within dysplastic areas in WAP-Shh/Ptch1-lacZ fourth lactation day
1 mammary tissue is 5.170.6 to 1. (C) PCNA(þ)/integrin b3() to PCNA(þ)/integrin b3(þ) cell ratio within dysplastic areas in WAP-Shh/Ptch1-lacZ fourth lactation day
1 mammary tissue is 11.8870.1 to1. (D–J) PCNA immunoﬂuorescence detection on Ptch1-lacZ control (E and G) and hyperplastic WAP-Shh/Ptch1-lacZ (D, F, H–J) fourth
lactation day 1 mammary tissues. (D–F) b-gal/PCNA immunoﬂuorescence detection. (G and H) K14/PCNA immunoﬂuorescence detection. Arrows in D, F and H show
PCNA-positive luminal cells adjacent to PCNA-negative hyperplastic basal epithelium. (I and J) PCNA and b3-integrin staining. Clusters of PCNA negative cells (I, arrow) are
b3-integrin positive (J, arrow; a-PCNA mouse monoclonal antibody yielded some non-speciﬁc cytoplasmic staining).
E. Garcı´a-Zaragoza et al. / Developmental Biology 372 (2012) 28–44 395.170.6–1 (Fig. 7B, illustrated in Fig. 7D and F, arrows).These data
suggest that Hh-responding cells in our transgenic mammary
model are slow cycling.In addition, double immunoﬂuorescence staining for integrin
b3 and PCNA showed that PCNA positive cells did not coincide
with integrin b3-expressing cells in WAP-Shh/Ptch1-lacZ basal
Fig. 8. Hh-responsive cells in WAP-Shh/Ptch1-lacZ mammary tissue present primary cilia.Confocal laser scanning immunoﬂuorescence detection of primary cilia in
parafﬁn sections from Ptch1-lacZ control (A and E) and WAP-Shh/Ptch1-lacZ basal cell hyperplasias (B–D and F). (A–C) b-gal/acetylated tubulin staining: (B) b-gal-
expressing cells exhibited primary cilia (white arrow) as detected by acetylated tubulin staining, while b-gal negative cells (blue nuclei) do not present cilia; (C) higher
magniﬁcation of (B) showing correlation between Hh responsiveness (b-gal expression) and cilia presence; (D) Acetylated tubulin/gamma tubulin immunoﬂuorescence
analysis identifying the green shafts as cilia. Gamma-tubulin, a marker for centrioles and basal body of cilia, is localized near the cilia marker acetylated tubulin (arrow).
The ellipse delineates a DAPI-stained nucleus. (E, F) Acetylated tubulin/Gli2 in Ptch1-lacZ control (E) and WAP-Shh/Ptch1-lacZ basal cell hyperplasia (F) staining showing
that ciliated cells in WAP-Shh/Ptch1-lacZ hyperplasias present nuclear Gli2 staining (F, arrow).
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integrin() to PCNA (þ)/b3 integrin(þ) cell ratio was
11.8870.1–1 (Fig. 7C) suggesting that, within the Hh-
responding cells, the subset expressing integrin b3 proliferated
at a even slower rate.
Hedgehog-responsive cells in WAP-Shh/Ptch1-lacZ mammary tissue
presented primary cilia.
Hh signaling is tightly related to a cellular organelle, the
primary cilium, a dynamic structure that grows in some quiescent
cells. Double immunostaining for ciliary acetylated tubulin and
b-gal showed abundant cilia in areas with many Hh-responsive
cells in WAP-Shh/Ptch1-lacZ mammary hyperplasias (Fig. 8B,
white arrow, magniﬁed in C). A complete correlation between
hedgehog responsiveness (b- gal positive cells) and cilia presence
was observed. In contrast, very scarce cilia were found in myoe-
pithelial and stromal cells of b-gal-negative Ptch1-lacZ lactating
control mammary tissue (Fig. 8A). To conﬁrm that these structures
are bona ﬁde primary cilia we double-stained with ciliary basal
body marker gamma tubulin and ciliary shaft marker acetylated
tubulin, and found adjacent location of both markers as predicted
(Fig. 8D, arrow).
Double immunoﬂuorescence staining for Gli2 and acetylated
tubulin showed colocalization of nuclear Gli2 and cilia in
WAP-Shh/Ptch1-lacZ dysplastic areas (Fig. 8F), further showing
that Hh pathway activation correlates with cilia presence in the
mammary gland.Discussion
We have investigated Hh signaling in the lactating mammary
gland and determined the effects of Hh pathway misactivation
in the mammary tissue. Our model is based on transgenic over-
expression of Hh ligand in luminal epithelium, the site of Hh
expression in mouse and human mammary gland and breast
tumors (Gallego et al., 2002; Lewis et al., 2001; O’Toole et al.,
2011) and in other organs (Podlasek et al., 1999). We have
established our Shh mammary overexpression model in a hemi-
zygous Ptch1 background, breeding WAP-Shh mice to mice
carrying a Ptch1-lacZ knock-in null allele. This allows visualiza-
tion of pathway activation through detection of the nuclear
b-gal protein. The presence of this null allele also results in
itself in limited activation of the Hh pathway (Goodrich et al.,
1997). In fact, development of mammary ductal dysplasias
and hyperplasias in postpubescence virgin mice carrying
this allele constituted the ﬁrst evidence of the implication of
the Hh pathway in mammary biology (Lewis et al., 1999).
Our model, based on lactation-driven expression of Shh, has
allowed us to focus on the Hh pathway activity in lactating
mammary glands.
Hh-responding cells accumulated in areas that resembled
benign human mammary intraductal proliferative lesions (ductal
hyperplasia or lobular intraepithelial hyperplasia) found
in human mammary pathologies (Cardiff and Wellings, 1999).
These lesions were found after extensive induction of Shh
transgene expression in WAP-Shh/Ptch1-lacZ transgenic mam-
mary glands, consistent with the Hh pathway being overtly active
in the mammary tissue only when constitutive repression is over-
ridden by overexpression or mutation of pathway elements.
This is in agreement with previous observations that suggest that
Hh unresponsiveness is characteristic of mammary tissues
(Hatsell and Frost, 2007). Evidence of functional activation of
the Hh pathway in the dysplastic areas was provided by the
nuclear localization of Gli2, the initial executor of Hh-inducedtranscriptional activation, in ciliated cells from these areas that
also overexpressed p63, a marker for Hh responsiveness in
our model.
We have found that secretory mammary epithelium-derived
Shh protein does not activate the Hh pathway in the cells that
produce Shh in an autocrine fashion. Instead, Hh responding cells
were located adjacent to secretory epithelial cells in a distinct
differentiation compartment, suggesting that Hh signaling in
mammary tissue, in the conditions established in our model, is
mostly intraepithelial and paracrine. Paracrine Hh signaling has
been described during the development of the digestive tract and
prostate (Mao et al., 2010; Yu et al., 2009) and during ovarian,
colon (Yauch et al., 2008), prostate (Shaw et al., 2009), pancreas
(Bailey et al., 2009) and breast (O’Toole et al., 2011) cancer
progression. In all mentioned cases, Hh secreted by epithelial
cells activates the Hh pathway in adjacent mesenchymal cells.
However, intraepithelial Hh signaling has also been described and
might play a role in stimulating the proliferation of progenitor
cells of organs and tumors (Beachy et al., 2004; Landsman et al.,
2011; Watkins et al., 2003).
The signaling mechanism that we describe here involves two
different types of epithelial mammary cells: a mature secretory
luminal cell that expresses Shh and a basally located Hh-
responding cell found in hyperplastic ducts and alveoli. Although
we found that the stroma is thicker and collagen I deposition is
increased in areas adjacent to the hyperplastic Hh-responsive
areas, we did not detect b-gal staining in mesenchymal cells in
these regions, suggesting that these extracellular matrix altera-
tions are secondary to the activation of the pathway in adjacent
epithelia. According to these data, intraepithelial Hh signaling,
rather than signaling involving epithelial-mesenchymal interac-
tions, seems to be prevalent in the mammary tissue. A recent
report shows that the Hh pathway is activated in mesenchymal
cells in the stroma of breast tumors in response to tumor-derived
Hh ligands (O’Toole et al., 2011). This apparent discrepancy with
our data might be explained by a different behavior of the
tumoral stroma, a highly dynamic environment that changes
with tumor progression, and the stroma of the non-neoplasic
mammary gland (Mukherjee et al., 2006). In spite of the presence
of basal cell hyperplasias and dysplasias in their mammary
glands, multiparous WAP-Shh/Ptch1-lacZ female mice did not
develop spontaneous mammary tumors, hindering the study of
Hh signaling in mouse mammary gland tumorigenesis. Aging
transgenic and non- transgenic littermates developed occasional
squamous metaplasias, but Hedgehog pathway activity was not
found in these lesions, as determined by the absence of b-gal
immunostaining (data not shown).
Analysis of the expression pattern of differentiation markers
suggests that Hh-responding cells might be related to progenitor
cells. We found a strong expression of basal markers p63, and
keratins 5, 14 and 17 in Ptch1-lacZ-expressing cells, remarkably
higher than that found in adjacent mammary myoepithelial
cells. This upregulation of basal markers contrasts with the
absence of smooth muscle actin expression, readily detectable
in the adjacent myoepithelium. The expression of basal keratins
in the mammary progenitor pool has been previously described
(Dontu et al., 2003; Shackleton et al., 2006; Stingl et al., 2006) and
overexpression of K5 in combination with absence of SMA has
been documented as a hallmark of the putative progenitor cell
(Bocker et al., 2002; Gudjonsson et al., 2005; Kittrell et al., 2011).
Despite their basal location, the cuboidal morphology of Hh-
responding cells clearly differentiated them from the ﬂattened,
polarized mature myoepithelial cells. Overexpression and sym-
metrical deposition of collagen IV in these cells, reﬂecting their
loss of baso-lateral polarity, further illustrates their incomplete
differentiation.
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and keratin 15 (Asselin-Labat et al., 2007; Celis et al., 2007) in
partially overlapping groups of Hh-responding cells, as well as the
sporadic expression of progenitor cell marker K6 (Bu et al., 2011)
in adjacent cells, suggests that Hh signaling misactivation might
cause the expansion of different populations of mammary pro-
genitor cells. This expansion could reﬂect an increased prolifera-
tion rate of preexistent progenitor cells. A role for Hh signaling in
stem and progenitor cell proliferation has been previously
described (Li et al., 2008; Liu et al., 2006). Increased presence of
cells expressing basal markers (but not SMA) in the second and
subsequent lactations may be the result of impaired differentia-
tion of lobular progenitor cells or parity-identiﬁed mammary
epithelial cells (PI-MECs) (Wagner et al., 2002; Boulanger et al.,
2005) to functional myoepithelial cells in developing lobules.
Altered differentiation of mammary progenitor cells has been
reported in a recently described transgenic model of ligand-
independent activation of the Hh pathway in mammary epithe-
lium (Visbal et al., 2011). Other mechanisms might also contri-
bute to progenitor cell accumulation. Dedifferentiation of
myoepithelial cells to an undifferentiated basal progenitor phe-
notype and subsequent slow proliferation of these dedifferen-
tiated cells might occur, resulting in the substitution of the
mature myoepithelium by a single layer of cuboidal basal cells,
as we observe in hyperplastic ducts. Hh signaling has been
associated with dedifferentiation of mature b-cells to undiffer-
entiated pancreatic tumoral cells (Landsman et al., 2011). Similar
mechanisms might operate in other organs such as prostate,
pancreas, lung and liver, in which regulation of the progenitor
cell compartment by intraepithelial hedgehog signaling has been
reported (Karhadkar et al., 2004; Lau and Hebrok, 2010; Sicklick
et al., 2006; Watkins et al., 2003).
Another characteristic of the Hh-responding cells in the
mammary epithelium is the presence of cilia. This organelle has
recently emerged as a crucial regulator of signal transduction
(Goetz et al., 2009). Genetic data proved that it is necessary for Hh
pathway activation (Huangfu et al., 2003) and Hedgehog respon-
siveness correlates with the presence of primary cilia in prostatic
and pancreatic normal and tumoral tissue (Zhang et al., 2009;
Cervantes et al., 2010). In the mature mammary gland, cilia have
been found in epithelial and mesenchymal cells (McDermott
et al., 2010) and mutant mice lacking cilia present mammary
branching defects that correlate with a signiﬁcant decrease in Gli1
expression (McDermott et al., 2010).
We showed herein for the ﬁrst time the correlation between
Hh responsiveness and the presence of cilia in the mammary
gland, since Hh-responding cells were ciliated and cilia were very
rare in non-responding areas. Mesenchymal cells in the extra-
cellular matrix adjacent to Hh-responsive epithelia did not dis-
play a signiﬁcant increase of primary cilia, consistent with the
absence of b-gal staining in these cells.
Cilia-dependent regulation of other signaling pathways has
also been reported. In particular, modulation of Wnt signaling
by sequestration of Wnt pathway components to the cilia has
recently been shown (Ajima and Hamada, 2011) and Wnt activa-
tion occurred in the mammary glands of mutant mice lacking cilia
(McDermott et al., 2010). Consistently, the Wnt pathway was not
active in the ciliated, Hh-responsive mammary epithelial cells of
our transgenic model, as determined by the location of b-catenin,
a Wnt signal transduction effector was absent from the nucleus
and cytoplasm of these cells. This suggests that Wnt pathway
activation, a common event in mouse mammary hyperplasias,
does not underlie the morphological alterations found in Hh-
responsive ciliated regions.
Recent data established that ciliogenesis and cell cycle pro-
gression are mutually exclusive, since recruitment of a centrioleto the cilium basal body is not compatible with mitotic spindle
formation (Pan and Snell, 2007) and ciliogenesis might play a role
in cell cycle control (Kim et al., 2011). Consistently, we found that
Hh-responding cells were slow-cycling, as assessed by PCNA
expression. This observation is in agreement with a previous
report showing that epithelial proliferation in a transgenic mouse
model expressing a constitutively active Smoothened (MMTV-
Smo M2) in mammary epithelium, was restricted to Smo M2-
negative mammary epithelial cells adjacent to Smo M2-
expressing cells (Visbal et al., 2011).
Using a transgenic model that allows to clearly distinguish Hh
ligand-expressing and Hh-responding cells we have found that
Hh pathway activation causes increased progenitor cell markers
expression and altered differentiation in the mammary gland via
a mechanism involving the interaction between two different
types of mammary epithelial cells. This intraepithelial paracrine
interaction might be at work in pathological mammary situations
such as mammary benign hyperplasias, that constitute a risk
factor for subsequent tumor malignant pathologies (Dupont and
Page, 1985), and in the self-renewal of the cancer stem cells
during tumor progression.Acknowledgments
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